Albara Ramli

Dr. Albara Ramli

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2022
Verified
Book Chapter
Closed access
PDF file
RLRex Liu
Rex Liu
ARAlbara Ramli
Albara Ramli
HZHuanle Zhang
Huanle Zhang
EHErik Henricson
Erik Henricson
XLXin Liu
Xin Liu

8 February 2024 in Sensors
Verified
Journal Article
Open access
PDF file
ARAlbara Ramli
Albara Ramli
XLXin Liu
Xin Liu
KBKelly Berndt
Kelly Berndt
EGErica Goude
Erica Goude
JHJiahui Hou
Jiahui Hou
EHErik Henricson
Erik Henricson
Differences in gait patterns of children with Duchenne muscular dystrophy (DMD) and typically developing (TD) peers are visible to the eye, but quantifications of those differences outside of the gait laboratory have been elusive. In this work, we measured vertical, mediolateral, and anteroposterior acceleration using a waist-worn iPhone accelerometer during ambulation across a typical range of velocities. Fifteen TD and fifteen DMD children from 3 to 16 years of age underwent eight walking/running activities, including five 25 m walk/run speed-calibration tests at a slow walk to running speeds (SC-L1 to SC-L5), a 6-min walk test (6MWT), a 100 m fast walk/jog/run (100MRW), and a free walk (FW). For clinical anchoring purposes, participants completed a Northstar Ambulatory Assessment (NSAA). We extracted temporospatial gait clinical features (CFs) and applied multiple machine learning (ML) approaches to differentiate between DMD and TD children using extracted temporospatial gait CFs and raw data. Extracted temporospatial gait CFs showed reduced step length and a greater mediolateral component of total power (TP) consistent with shorter strides and Trendelenberg-like gait commonly observed in DMD. ML approaches using temporospatial gait CFs and raw data varied in effectiveness at differentiating between DMD and TD controls at different speeds, with an accuracy of up to 100%. We demonstrate that by using ML with accelerometer data from a consumer-grade smartphone, we can capture DMD-associated gait characteristics in toddlers to teens.

9 February 2024 in Sensors
Verified
Journal Article
Open access
PDF file
ARAlbara Ramli
Albara Ramli
XLXin Liu
Xin Liu
KBKelly Berndt
Kelly Berndt
CCChen-Nee Chuah
Chen-Nee Chuah
EGErica Goude
Erica Goude
EHErik Henricson
Erik Henricson
Estimation of temporospatial clinical features of gait (CFs), such as step count and length, step duration, step frequency, gait speed, and distance traveled, is an important component of community-based mobility evaluation using wearable accelerometers. However, accurate unsupervised computerized measurement of CFs of individuals with Duchenne muscular dystrophy (DMD) who have progressive loss of ambulatory mobility is difficult due to differences in patterns and magnitudes of acceleration across their range of attainable gait velocities. This paper proposes a novel calibration method. It aims to detect steps, estimate stride lengths, and determine travel distance. The approach involves a combination of clinical observation, machine-learning-based step detection, and regression-based stride length prediction. The method demonstrates high accuracy in children with DMD and typically developing controls (TDs) regardless of the participant’s level of ability. Fifteen children with DMD and fifteen TDs underwent supervised clinical testing across a range of gait speeds using 10 m or 25 m run/walk (10 MRW, 25 MRW), 100 m run/walk (100 MRW), 6-min walk (6 MWT), and free-walk (FW) evaluations while wearing a mobile-phone-based accelerometer at the waist near the body’s center of mass. Following calibration by a trained clinical evaluator, CFs were extracted from the accelerometer data using a multi-step machine-learning-based process and the results were compared to ground-truth observation data. Model predictions vs. observed values for step counts, distance traveled, and step length showed a strong correlation (Pearson’s r = −0.9929 to 0.9986, p < 0.0001). The estimates demonstrated a mean (SD) percentage error of 1.49% (7.04%) for step counts, 1.18% (9.91%) for distance traveled, and 0.37% (7.52%) for step length compared to ground-truth observations for the combined 6 MWT, 100 MRW, and FW tasks. Our study findings indicate that a single waist-worn accelerometer calibrated to an individual’s stride characteristics using our methods accurately measures CFs and estimates travel distances across a common range of gait speeds in both DMD and TD peers.

18 September 2020
Verified
Book Chapter
Closed access
PDF file
ARAlbara Ramli
Albara Ramli
RLRex Liu
Rex Liu
RKRahul Krishnamoorthy
Rahul Krishnamoorthy
IVI. B. Vishal
I. B. Vishal
XWXiaoxiao Wang
Xiaoxiao Wang
XLXin Liu
Xin Liu

21 May 2025 in Sensors
Verified
Journal Article
Open access
PDF file
EHErik Henricson
Erik Henricson
ARAlbara Ramli
Albara Ramli
Accurate estimation of gait characteristics, including step length, step velocity, and travel distance, is critical for assessing mobility in toddlers, children, and teens with Duchenne muscular dystrophy (DMD) and typically developing (TD) peers. This study introduces a novel method leveraging Fast Fourier Transform (FFT)-derived step frequency from a single waist-worn consumer-grade accelerometer to predict gait parameters efficiently. The proposed FFT-based step frequency detection approach, combined with regression-derived stride length estimation, enables precise measurement of temporospatial gait features across various walking and running speeds. Our model, developed from a diverse cohort of children aged 3–16, demonstrated high accuracy in step length estimation (R2=0.92, RMSE=0.06 m) using only step frequency and height as inputs. Comparative analysis with ground-truth observations and AI-driven Walk4Me models validated the FFT-based method, showing strong agreement across step count, step frequency, step length, step velocity, and travel distance metrics. The results highlight the feasibility of using widely available mobile devices for gait assessment in real-world settings, offering a scalable solution for monitoring disease progression and mobility changes in individuals with DMD. Future work will focus on refining model performance and expanding applicability to additional movement disorders.

18 January 2023 in arXiv
Verified
Preprint
Open access
PDF file
RLRex Liu
Rex Liu
ARAlbara Ramli
Albara Ramli
HZHuanle Zhang
Huanle Zhang
EHErik Henricson
Erik Henricson
XLXin Liu
Xin Liu
With the rapid development of the internet of things (IoT) and artificial intelligence (AI) technologies, human activity recognition (HAR) has been applied in a variety of domains such as security and surveillance, human-robot interaction, and entertainment. Even though a number of surveys and review papers have been published, there is a lack of HAR overview papers focusing on healthcare applications that use wearable sensors. Therefore, we fill in the gap by presenting this overview paper. In particular, we present our projects to illustrate the system design of HAR applications for healthcare. Our projects include early mobility identification of human activities for intensive care unit (ICU) patients and gait analysis of Duchenne muscular dystrophy (DMD) patients. We cover essential components of designing HAR systems including sensor factors (e.g., type, number, and placement location), AI model selection (e.g., classical machine learning models versus deep learning models), and feature engineering. In addition, we highlight the challenges of such healthcare-oriented HAR systems and propose several research opportunities for both the medical and the computer science community.